Astellas Pharma Inc. (ALPMY)
OTCMKTS
· Delayed Price · Currency is USD
9.73
+0.10 (1.04%)
Apr 1, 2025, 3:58 PM EST
Astellas Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,516 | 19,482 | 25,437 | 28,985 | 28,585 | 28,860 | Upgrade
|
| Market Cap Growth | -18.52% | -23.41% | -12.24% | 1.40% | -0.95% | 0.37% | Upgrade
|
| Enterprise Value | 22,442 | 23,368 | 22,361 | 25,959 | 25,644 | 26,309 | Upgrade
|
| Last Close Price | 9.73 | 10.75 | 14.20 | 15.58 | 15.44 | 15.24 | Upgrade
|
| PE Ratio | - | 172.88 | 34.26 | 28.37 | 26.22 | 15.89 | Upgrade
|
| PS Ratio | 1.47 | 1.84 | 2.23 | 2.72 | 2.53 | 2.39 | Upgrade
|
| PB Ratio | 1.84 | 1.85 | 2.24 | 2.41 | 2.28 | 2.41 | Upgrade
|
| P/TBV Ratio | - | - | 5.48 | 6.59 | 7.02 | 10.97 | Upgrade
|
| P/FCF Ratio | 21.53 | 21.92 | 11.61 | 15.53 | 11.48 | 17.18 | Upgrade
|
| P/OCF Ratio | 16.61 | 17.09 | 10.32 | 13.67 | 10.30 | 13.99 | Upgrade
|
| EV/Sales Ratio | 1.79 | 2.20 | 1.96 | 2.43 | 2.27 | 2.18 | Upgrade
|
| EV/EBITDA Ratio | 8.44 | 12.51 | 8.81 | 10.58 | 8.77 | 8.48 | Upgrade
|
| EV/EBIT Ratio | 17.00 | 28.37 | 12.83 | 14.45 | 11.30 | 10.58 | Upgrade
|
| EV/FCF Ratio | 27.66 | 26.29 | 10.20 | 13.91 | 10.30 | 15.66 | Upgrade
|
| Debt / Equity Ratio | 0.61 | 0.63 | 0.14 | 0.15 | 0.20 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 2.29 | 3.57 | 0.61 | 0.72 | 0.86 | 1.25 | Upgrade
|
| Debt / FCF Ratio | 7.18 | 7.50 | 0.70 | 0.94 | 1.01 | 2.30 | Upgrade
|
| Asset Turnover | 0.55 | 0.53 | 0.63 | 0.56 | 0.54 | 0.62 | Upgrade
|
| Inventory Turnover | 1.35 | 1.38 | 1.76 | 1.60 | 1.56 | 1.83 | Upgrade
|
| Quick Ratio | 0.73 | 0.69 | 1.13 | 1.05 | 1.15 | 0.86 | Upgrade
|
| Current Ratio | 1.05 | 0.93 | 1.45 | 1.34 | 1.47 | 1.09 | Upgrade
|
| Return on Equity (ROE) | -3.83% | 1.10% | 6.65% | 8.72% | 9.01% | 15.34% | Upgrade
|
| Return on Assets (ROA) | 3.67% | 2.58% | 6.05% | 5.92% | 6.83% | 7.93% | Upgrade
|
| Return on Capital (ROIC) | 5.24% | 3.61% | 8.55% | 8.17% | 9.31% | 11.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.70% | 5.50% | 13.40% | 13.30% | 14.90% | 17.60% | Upgrade
|
| Earnings Yield | -2.09% | 0.58% | 2.92% | 3.52% | 3.81% | 6.29% | Upgrade
|
| FCF Yield | 4.63% | 4.56% | 8.62% | 6.44% | 8.71% | 5.82% | Upgrade
|
| Dividend Yield | 5.20% | 4.30% | 3.18% | 2.64% | 2.46% | 2.44% | Upgrade
|
| Payout Ratio | 0.00% | 684.38% | 101.66% | 68.69% | 63.15% | 37.63% | Upgrade
|
| Buyback Yield / Dilution | 0.88% | 1.39% | 1.38% | 0.41% | 1.03% | 2.91% | Upgrade
|
| Total Shareholder Return | 5.97% | 5.70% | 4.56% | 3.05% | 3.49% | 5.34% | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.